Reply
- PMID: 26982516
- DOI: 10.1097/j.pain.0000000000000467
Reply
Comment on
-
Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial.Pain. 2015 Feb;156(2):280-288. doi: 10.1097/01.j.pain.0000460308.86819.aa. Pain. 2015. PMID: 25599449 Free PMC article. Clinical Trial.
-
Unexplained resolution of diagnosed hypogonadism.Pain. 2016 Apr;157(4):990. doi: 10.1097/j.pain.0000000000000468. Pain. 2016. PMID: 26982515 No abstract available.
References
-
- Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005;34:215–20.
-
- Basaria S, Travison TG, Alford D, Knapp PE, Teeter K, Cahalan C, Eder R, Lakshman K, Bachman E, Mensing G, Martel MO, Le D, Stroh H, Bhasin S, Wasan AD, Edwards RR. Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized-controlled trial. PAIN 2015;156:280–88.
-
- Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM; Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2010;95:2536–59.
-
- Rubinstein A, Carpenter DM. Elucidating risk factors for androgen deficiency associated with daily opioid use. Am J Med 2014;127:1195–201.
-
- Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010;31:98–132.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
